You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings

    SBC: HEALTH DECISION TECHNOLOGIES, LLC            Topic: NIDCR

    DESCRIPTION provided by applicant Evaluation of dental tobacco cessation tool in practice based research network This Phase II project will finish development and evaluate QuitAdvisorDDS as a tool for dental providers to advise patients on tobacco cessation The University of Kentucky will evaluate the effectiveness of QuitAdvisorDDS in increasing quit attempts in tobacco using patients The ev ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Imaging Software of Functional Connectivity MRI for Alzheimer's Disease

    SBC: BRAINSYMPHONICS, LLC            Topic: NIA

    DESCRIPTION provided by applicant This application andquot Imaging Software of Functional Connectivity MRI for Alzheimerandapos s Diseaseandquot is written in response to PA andquot Lab to Marketplace Tools for Brain and Behavioral Research SBIR R R andquot Alzheimerandapos s disease AD is the most common form of dementia However developing drugs that effectively slow or alter the course of Alzhei ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  3. Reducing Health Disparities: A Health IT Solution

    SBC: MY COVERAGE PLAN INC.            Topic: NIMHD

    DESCRIPTION provided by applicant My Coverage Plan Inc MCP proposes to use our newly patented technology to create a commercially viable and nationally replicable suite of software and services for health care providers and other social service agencies that reduces avoidable health disparities and increases provider reimbursements The MCP health IT solution will help providers proactively ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Biomarker discovery for immunodiagnosis of invasive candidiasis

    SBC: DxDiscovery Incorporated            Topic: NIAID

    DESCRIPTION (provided by applicant): Invasive candidiasis (IC) is one of the most serious threats to patients in a critical setting. With as many as 60,000 cases per year in the U.S., the total cost associated with IC in the U.S. may be as high as 2-4 billion/year. One of the most critical factors influencing patient outcome is early diagnosis. The goal of this project is a rapi and inexpensive i ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Neuroimaging tools for presurgical brain mapping

    SBC: PRISM CLINICAL IMAGING, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): The goal of this project is to develop functional magnetic resonance imaging (fMRI) tools to assist the diagnosis and treatment of human patients with a brain tumor or other operable pathology. The specific focus of this proposal is to produce a practical, clinic-ready suite of MR imaging methods, analyses and display tools to solve the number one impediment to ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Presurgical brain mapping with functional connectivity MRI

    SBC: PRISM CLINICAL IMAGING, INC.            Topic: NINDS

    DESCRIPTION (provided by applicant): The diagnosis and treatment of patients with brain tumors and other diseases is often critically dependent on functional neuroimaging (e.g. fMRI) to identify healthy brain tissue that must be avoided during invasive surgery or radiation treatment. But, conventional fMRI often fails (up to 30 percent) or cannot be used with patients who are unable to adequately ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Development of a new approach to screening for language impairments

    SBC: InseRT            Topic: NCI

    Significance: Accurate targeting, guidance and monitoring of interventional therapy in the brain are critical for maximizing the effectiveness and safety during and following neurosurgical procedures. Magnetic resonance imaging (MRI) is a critical tool forplanning and guiding neurosurgical procedures. In most cases, the MRI is obtained during a pre-operative session; however, either brain shift, e ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Ontology-Based Knowledge and Belief Management System

    SBC: NitricGen inc.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Healing of Diabetic Ulcers with Gaseous Nitric Oxide Generated from Room Air Diabetic foot ulcers (DFUs) are a frequent and debilitating complication of diabetes, and affect 1-2.5 million patients in the US. Many DFUs remain unhealed, leading to extensive hospitalizations and the increased risk of infections, amputations, and death. Patients with DFUs that do n ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. hiPS Derived Assay for Screening Hematopoietic Differentiation Toxicant Effects

    SBC: PRIMORIGEN BIOSCIENCES INC.            Topic: NIEHS

    Primorigen Biosciences (R) Abstract Primorigen Biosciences will use SBIR funds to develop a high-throughput toxicology assay system utilizing human ventricular cardiomyocytes (vCMs) differentiated from human induced pluripotent stem cells (hiPSCs). Phase Istudies will convert the small-molecule based, cytokine-free CardioTotal differentiation technology into a 96-well based high-throughput format ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Polynitroxylated Pegylated Hemoglobin for Traumatic Brian Injury Resuscitation

    SBC: PRIMORIGEN BIOSCIENCES INC.            Topic: NIEHS

    Primorigen Biosciences (R) Abstract Primorigen Biosciences will use SBIR funds to develop a novel commercial assay that measures the toxicity of compounds on human induced pluripotent stem cells (hiPSCs) differentiating into hematopoietic progenitor cells(HPCs) and on HPCs differentiated from hiPSCs. The assay will rely on Primorigen's highly efficient, patent-pending MesoTotal medium for di ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government